Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centogene N.V. - Common Shares (NQ:CNTG)

0.3250 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centogene N.V. - Common Shares

< Previous 1 2 3 4 5 Next >
News headline image
CENTOGENE Accelerates Global Genetic Data Interpretation, Launching FilterTool Application as Accessory to CentoCloud® Bioinformatics Pipeline
From Centogene NV
Via GlobeNewswire
News headline image
Why GE HealthCare Technologies Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers 
Via Benzinga
News headline image
Analyst: Centogene Leveraging The Largest BioDatabank For Rare Diseases ↗
 
Via Benzinga
News headline image
CENTOGENE to Participate in Upcoming Conferences in April
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Launches NEW CentoGenome®, World’s Most Comprehensive Whole Genome Sequencing Solution for Diagnosis of Rare and Neurodegenerative Diseases
From Centogene NV
Via GlobeNewswire
News headline image
Why National CineMedia Shares Are Trading Higher By Around 111%; Here Are 20 Stocks Moving Premarket ↗
Gainers National CineMedia, Inc. (NASDAQ: NCMI) jumped 111.2% to $0.2810 in pre-market trading after a 13G filing showed a 9.1% passive stake in the company from AMC Entertainment. 
Via Benzinga
News headline image
Why Kalera Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 164% to $3.86 after the company announced it launched ChatGPT-enabled smart eyewear. 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting off the day with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on Tuesday! 
Via InvestorPlace
News headline image
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Appoints Ian Rentsch as Chief Commercial Officer and General Manager - Pharma
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in March
From Centogene NV
Via GlobeNewswire
News headline image
In the Lead-Up to Rare Disease Day, CENTOGENE Expands Observational Study to Advance the Genetic Understanding of Frontotemporal Dementia (FTD)
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Conferences in February in the Lead Up to Rare Disease Day
From Centogene NV
Via GlobeNewswire
News headline image
Twist Bioscience and CENTOGENE Launch Three Panels to Advance Rare Disease and Hereditary Cancer Research and Support Diagnostics
From Twist Bioscience Corporation
Via Business Wire
News headline image
CENTOGENE and Denali Therapeutics Extend World’s Largest Observational Study on Parkinson’s Disease Genetics
Working together to deliver data-driven, informative genotyping answers to accelerate and de-risk drug discovery, development, and commercialization for Parkinson’s disease (PD) 
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
News headline image
Why Quotient Shares Are Trading Lower By More Than 48%; Here Are 37 Stocks Moving Premarket ↗
Gainers Netcapital Inc. (NASDAQ: NCPL) shares rose 91.3% to $2.65 in pre-market trading following Q2 results. Netcapital posted Q2 earnings of $0.04 per share on sales of $1.78 million. 
Via Benzinga
News headline image
CENTOGENE to Participate in Upcoming Conferences in December
From Centogene NV
Via GlobeNewswire
News headline image
Why Taboola Shares Are Trading Higher By Around 53%? Here Are 53 Stocks Moving In Monday's Mid-Day Session ↗
Gainers Taboola.com Ltd. (NASDAQ: TBLA) shares gained 52.5% to $2.8050 after the company announced it entered into a 30-year exclusive commercial agreement with Yahoo. 
Via Benzinga
News headline image
CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
Adding significant financial expertise with an impressive track record in value creation 
From Centogene NV
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Wednesday ↗
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 34 companies set new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  Monday saw 33 companies set new 52-week lows. 
Via Benzinga
News headline image
CENTOGENE to Participate in Upcoming Conferences in November
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Launches Rare and Neurodegenerative Disease Biodata Network
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE to Participate in Upcoming Partnering Conferences in October
From Centogene NV
Via GlobeNewswire
News headline image
CENTOGENE Reaches 12,500 Patient Milestone in World’s Largest Observational Study on Parkinson’s Disease Genetics
From Centogene NV
Via GlobeNewswire
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.